Vivo Capital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001674712 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 9, 2018

Total Value: $467M (100.0% shares, 0.0% debt)

Holdings (30)

ASND Ascendis Pharma 15.2%

Value $70.78M Shares 1,766,832 Est. Cost $17.51 Unrealized —

— Biohaven Pharmaceutical Holding Company Ltd 11.4%

Value $53.34M Shares 1,976,818 Est. Cost $37.38 Unrealized —

ACRS Aclaris Therapeutics 8.7%

Value $40.62M Shares 1,647,214 Est. Cost $19.11 Unrealized +27.4%

APLS Apellis Pharmaceuticals, Inc. 6.8%

Value $31.64M Shares 1,457,834 Est. Cost $14.72 Unrealized 0.0%

CDXS Codexis, Inc. 5.5%

Value $25.51M Shares 3,054,825 Est. Cost $3.85 Unrealized +79.5%

— Eiger BioPharmaceuticals 5.4%

Value $24.99M Shares 1,791,257 Est. Cost $16.42 Unrealized —

— Nabriva Therapeutics Plc 5.2%

Value $24.36M Shares 4,074,190 Est. Cost $8.19 Unrealized —

— Aimmune Therapeutics, Inc. 5.2%

Value $24.34M Shares 643,626 Est. Cost $10.99 Unrealized —

— Kala Pharmaceuticals, Inc. 4.6%

Value $21.43M Shares 1,158,911 Est. Cost $22.84 Unrealized —

— Advanced Accelerator Applications S.A. 4.4%

Value $20.34M Shares 249,241 Est. Cost $35.30 Unrealized —

— Strongbridge Biopharma Plc 3.8%

Value $17.78M Shares 2,452,397 Est. Cost $2.40 Unrealized —

— Verona Pharma Plc 3.8%

Value $17.72M Shares 1,492,951 Est. Cost $13.61 Unrealized —

— Kadmon Holdings, Inc. 2.6%

Value $12.07M Shares 3,333,333 Est. Cost $3.35 Unrealized —

— Selecta Biosciences, Inc. 2.4%

Value $10.98M Shares 1,119,189 Est. Cost $19.86 Unrealized —

— Amyris, Inc. 2.3%

Value $10.6M Shares 2,826,711 Est. Cost $3.20 Unrealized —

— Sierra Oncology, Inc 1.9%

Value $9.095M Shares 2,438,270 Est. Cost $1.55 Unrealized —

— Soleno Therapeutics, Inc. 1.6%

Value $7.26M Shares 4,033,534 Est. Cost $1.80 Unrealized —

ZLAB Zai Lab LTD 1.4%

Value $6.742M Shares 317,567 Est. Cost $27.00 Unrealized —

AUPH Aurinia Pharmaceuticals Inc. 1.2%

Value $5.496M Shares 1,213,290 Est. Cost $5.62 Unrealized -1.2%

RGNX Regenxbio Inc. 1.2%

Value $5.466M Shares 164,403 Est. Cost $12.80 Unrealized +135.4%

— Foamix Pharmaceuticals Ltd. 1.1%

Value $5.139M Shares 855,000 Est. Cost $9.26 Unrealized —

— Zogenix, Inc. 0.9%

Value $4.205M Shares 105,000 Est. Cost $40.05 Unrealized —

— Agile Therapeutics, Inc. 0.9%

Value $4.073M Shares 1,513,975 Est. Cost $6.21 Unrealized —

KALV KalVista Pharmaceuticals, Inc. 0.6%

Value $2.928M Shares 300,325 Est. Cost $7.13 Unrealized +46.0%

— Trevena, Inc. 0.6%

Value $2.765M Shares 1,728,000 Est. Cost $7.67 Unrealized —

CRSP CRISPR Therapeutics AG 0.5%

Value $2.313M Shares 98,511 Est. Cost $18.69 Unrealized +1.7%

— Sunesis Pharmaceuticals, Inc. 0.4%

Value $1.845M Shares 500,000 Est. Cost $3.62 Unrealized —

— BioPharmX Corporation 0.3%

Value $1.521M Shares 13,799,944 Est. Cost $0.38 Unrealized —

— Akari Therapeutics Plc 0.3%

Value $1.498M Shares 345,850 Est. Cost $14.00 Unrealized —

— Soleno Therapeutics, Inc. 0.0%

Value $27,000 Shares 188,772 Est. Cost $0.14 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ASND	Ascendis Pharma	1,766,832	$70.78M	15.2%	$17.51	—	ADR	04351P101
—	Biohaven Pharmaceutical Holding Company Ltd	1,976,818	$53.34M	11.4%	$37.38	—	Common	G11196105
ACRS	Aclaris Therapeutics	1,647,214	$40.62M	8.7%	$19.11	+27.4%	Common	00461U105
APLS	Apellis Pharmaceuticals, Inc.	1,457,834	$31.64M	6.8%	$14.72	0.0%	Common	03753U106
CDXS	Codexis, Inc.	3,054,825	$25.51M	5.5%	$3.85	+79.5%	Common	192005106
—	Eiger BioPharmaceuticals	1,791,257	$24.99M	5.4%	$16.42	—	Common	28249U105
—	Nabriva Therapeutics Plc	4,074,190	$24.36M	5.2%	$8.19	—	SHS	G63637105
—	Aimmune Therapeutics, Inc.	643,626	$24.34M	5.2%	$10.99	—	Common	00900T107
—	Kala Pharmaceuticals, Inc.	1,158,911	$21.43M	4.6%	$22.84	—	Common	483119103
—	Advanced Accelerator Applications S.A.	249,241	$20.34M	4.4%	$35.30	—	ADS	00790T100
—	Strongbridge Biopharma Plc	2,452,397	$17.78M	3.8%	$2.40	—	Ordinary Shares	G85347105
—	Verona Pharma Plc	1,492,951	$17.72M	3.8%	$13.61	—	ADS	925050106
—	Kadmon Holdings, Inc.	3,333,333	$12.07M	2.6%	$3.35	—	Common	48283N106
—	Selecta Biosciences, Inc.	1,119,189	$10.98M	2.4%	$19.86	—	Common	816212104
—	Amyris, Inc.	2,826,711	$10.6M	2.3%	$3.20	—	Common	03236M200
—	Sierra Oncology, Inc	2,438,270	$9.095M	1.9%	$1.55	—	Common	82640U107
—	Soleno Therapeutics, Inc.	4,033,534	$7.26M	1.6%	$1.80	—	Common	834203200
ZLAB	Zai Lab LTD	317,567	$6.742M	1.4%	$27.00	—	ADR	98887Q104
AUPH	Aurinia Pharmaceuticals Inc.	1,213,290	$5.496M	1.2%	$5.62	-1.2%	Common	05156V102
RGNX	Regenxbio Inc.	164,403	$5.466M	1.2%	$12.80	+135.4%	Common	75901B107
—	Foamix Pharmaceuticals Ltd.	855,000	$5.139M	1.1%	$9.26	—	SHS	M46135105
—	Zogenix, Inc.	105,000	$4.205M	0.9%	$40.05	—	Common	98978L204
—	Agile Therapeutics, Inc.	1,513,975	$4.073M	0.9%	$6.21	—	Common	00847L100
KALV	KalVista Pharmaceuticals, Inc.	300,325	$2.928M	0.6%	$7.13	+46.0%	Common	483497103
—	Trevena, Inc.	1,728,000	$2.765M	0.6%	$7.67	—	Common	89532E109
CRSP	CRISPR Therapeutics AG	98,511	$2.313M	0.5%	$18.69	+1.7%	NAMEN AKT	H17182108
—	Sunesis Pharmaceuticals, Inc.	500,000	$1.845M	0.4%	$3.62	—	Common Par	867328700
—	BioPharmX Corporation	13,799,944	$1.521M	0.3%	$0.38	—	Common	09072X101
—	Akari Therapeutics Plc	345,850	$1.498M	0.3%	$14.00	—	ADR	00972G108
—	Soleno Therapeutics, Inc.	188,772	$27,000	0.0%	$0.14	—	Warrant	834203135